The co-emergence of a six-layered cerebral neocortex and its corticospinal output system is one of the evolutionary hallmarks of mammals. However, the genetic programs that underlie their development and evolution remain poorly understood. Here we identify a conserved non-exonic element (E4) that acts as a cortex-specific enhancer for the nearby gene Fezf2 (also known as Fezl and Zfp312), which is required for the specification of corticospinal neuron identity and connectivity. We find that SOX4 and SOX11 functionally compete with the repressor SOX5 in the transactivation of E4. Cortex-specific double deletion of Sox4 and Sox11 leads to the loss of Fezf2 expression, failed specification of corticospinal neurons and, independent of Fezf2, a reeler-like inversion of layers. We show evidence supporting the emergence of functional SOX-binding sites in E4 during tetrapod evolution, and their subsequent stabilization in mammals and possibly amniotes. These findings reveal that SOX transcription factors converge onto a cis-acting element of Fezf2 and form critical components of a regulatory network controlling the identity and connectivity of corticospinal neurons.
The co-emergence of a six-layered cerebral neocortex and its corticospinal output system is one of the evolutionary hallmarks of mammals. However, the genetic programs that underlie their development and evolution remain poorly understood. Here we identify a conserved non-exonic element (E4) that acts as a cortex-specific enhancer for the nearby gene Fezf2 (also known as Fezl and Zfp312), which is required for the specification of corticospinal neuron identity and connectivity. We find that SOX4 and SOX11 functionally compete with the repressor SOX5 in the transactivation of E4. Cortex-specific double deletion of Sox4 and Sox11 leads to the loss of Fezf2 expression, failed specification of corticospinal neurons and, independent of Fezf2, a reeler-like inversion of layers. We show evidence supporting the emergence of functional SOX-binding sites in E4 during tetrapod evolution, and their subsequent stabilization in mammals and possibly amniotes. These findings reveal that SOX transcription factors converge onto a cis-acting element of Fezf2 and form critical components of a regulatory network controlling the identity and connectivity of corticospinal neurons.
The emergence and expansion of the neocortex in mammals has been crucial to the evolution of complex perceptual, cognitive, emotional and motor abilities [1] [2] [3] . The neocortex is organized into six layers based largely on the distinct subtypes of excitatory projection (or pyramidal) neurons and their patterns of connectivity [4] [5] [6] [7] [8] [9] . Upper-layer (L2, L3 and L4) projection neurons form synaptic connections solely with other cortical neurons. By contrast, the majority of neurons in the deeper layers (L5 and L6) project to subcortical regions. Studies of laminar inversion in reeler mice lacking the reelin (RELN) protein [10] [11] [12] [13] [14] have shown that neuron identity and connectivity are determined by birth order rather than by laminar position, suggesting that neuronal specification and positioning are largely separately encoded.
The layer-specific pattern of connectivity is dependent on cortical areas. The long-range projections of L5 neurons in somatosensorymotor areas form the corticospinal (CS) system that directly connects the neocortex with various subcortical regions [15] [16] [17] [18] [19] [20] [21] [22] . A major component of the system, the CS (or pyramidal) tract, descends through the brainstem and into the spinal cord to provide a high degree of direct control over the precise motor functions affected in many clinical conditions 21, 22 . Despite these important functional implications, the genetic programs controlling CS system development and evolution remain unclear.
Phenotypic specification and evolution of neural circuits depend on precise regulation of the timing, location and level of gene expression 23, 24 . Transcriptional control via cis-regulatory elements has emerged as a crucial mechanism [25] [26] [27] [28] [29] . The cis-regulatory mechanisms underlying the specification of distinct neuronal cell types and circuits, however, remain poorly understood. Specification of CS neurons and the formation of the CS tract critically depend on Fezf2, which encodes a zinc-finger transcription factor highly enriched in early cortical progenitor cells and their deep-layer neuron progenies [30] [31] [32] [33] [34] [35] . Inactivation of Fezf2 disrupts the molecular specification of deep-layer neurons and the formation of corticofugal projections, including the CS tract, without affecting the inside-out pattern of neurogenesis and lamination [33] [34] [35] . Misexpression of Fezf2 in L2 or L3 cortico-cortical projection neurons 35, 36 or striatal interneurons 37 alters their molecular profile and induces ectopic subcerebral projections. These findings indicate that the precisely regulated transcription of Fezf2 is probably critical to the proper specification of distinct types of cortical projection neurons.
In this study, we used bacterial artificial chromosome (BAC) engineering and genetic inactivation in mice to identify and characterize a cortex-specific Fezf2 enhancer and its trans-regulators. We show that three SOX transcription factors converge onto the Fezf2 enhancer to control CS system development via functional binding sites that emerged in tetrapods. We also found that Sox4 and Sox11 are required for Fezf2-independent regulation of cortical RELN expression and laminar organization. Thus, these findings reveal novel developmental genetic programs that control layer formation and CS neuron identity, and the regulatory mechanisms by which they may have evolved.
E4 enhancer controls cortical Fezf2 expression
Previously, it has been shown that the BAC transgenic mouse harbouring 200 kb of the mouse Fezf2 locus and the Gfp reporter gene (Fezf2-Gfp; ref. 38) recapitulates the spatio-temporal expression of endogenous Fezf2 (refs 39, 40) . This indicated that the cis-regulatory elements required for cortical Fezf2 expression are located within the BAC sequence. On the basis of the remarkable similarity in cortical expression pattern of Fezf2 between mouse and human 39, 41 , we proposed that the regulatory elements are also highly evolutionarily conserved. Comparative sequence analysis revealed several conserved non-exonic elements (CNEEs) within the Fezf2-Gfp BAC (Fig. 1a ). To test whether the selected CNEEs regulate Fezf2-Gfp expression, we generated multiple lines of BAC transgenic mice in which one of the CNEEs within the Fezf2-Gfp BAC was deleted (DE1 to DE4; Fig. 1b and Methods). We analysed GFP expression in whole-mount brain preparations and tissue sections of transgenic mice at embryonic and postnatal ages ( Fig. 1c-g and Supplementary Figs 1 and 2 ). We found no pronounced change in DE1, DE2 and DE3 mutants, which, like wild-type Fezf2-Gfp mice, expressed GFP in neocortex and pontine CS axons ( Fig. 1d-f ). By contrast, the deletion of CNEE E4 (DE4), which is located 7.3 kb downstream of the Fezf2 transcription start site, resulted in a drastic loss of GFP expression in the cortex but not in the hypothalamus or the olfactory bulb ( Fig. 1g ). Moreover, in DE4 mice, GFP-positive CS axon fascicles were lost from the ventral surface of the pons (Fig. 1g ). Consistent with this finding, E4 was identified as an in vivo binding site of the enhancer-associated protein EP300 in mouse embryonic forebrain 27 . Together, these results demonstrate that E4 is a cis-regulatory module acting as a cortexspecific enhancer of Fezf2.
Loss of Fezf2 expression and CS axons in E4 2/2 mice
To test the function of the E4 enhancer directly, we deleted the E4 region, while leaving intact the entire Fezf2 coding and proximal promoter regions, using homologous recombination in embryonic stem cells ( Fig. 2a, b ). Mice lacking E4 (E4 2/2 ) were viable, fertile and without overt behavioural or motor phenotypes. Quantitative reverse-transcription PCR (RT-PCR) analysis revealed that Fezf2 expression is drastically downregulated in neocortex of these mice ( Fig. 2c ). Immunostaining of tissue sections of E4-null mice for PRKCG and L1CAM, two proteins expressed by CS neurons and their axons 11 (Fig. 2d, e ), revealed that CS axons were absent from the pons ( Fig. 2g ), similar to mutant mice with a cortex-specific deletion of Fezf2 (Fezf2 fl/fl ;Emx1-Cre) ( Fig. 2f ). Furthermore, the expression of Bcl11b (Ctip2), a gene functioning downstream of Fezf2 (refs 33, 36) , was also downregulated in the E4-null neocortex ( Supplementary Fig. 3 ). Taken together, these results indicate that the E4 enhancer is required for neocortical Fezf2 expression, molecular specification of L5/6 neurons and the formation of CS tract.
SOX4 and SOX11 bind and activate the E4 enhancer
We have previously shown that SOX5, a SOXD member of the large family of SOX transcription factors, binds to and represses the transcriptional activity of the E4 enhancer 39 . Unexpectedly, SOX5 itself is also required for CS tract formation independent of its repression of Fezf2 (ref. 39) . Because different SOX transcription factors are known to compete for a common motif to mediate both activation and repression of regulatory elements [42] [43] [44] , we proposed that other SOX members may activate the E4 enhancer, perhaps acting competitively against SOX5-mediated repression. Consistent with this hypothesis, our sequence analysis using MATINSPECTOR (Genomatix) revealed eight putative SOX-binding sites in E4. To prioritize which SOX transcription factors may be good candidates for potential trans-regulators of the E4 enhancer, we searched for those that are most highly correlated in their spatio-temporal expression pattern with FEZF2, using the Human Brain Transcriptome database 45 (http://www.humanbraintranscriptome.org). The highest-correlated SOX genes were three members of the SOXC group (SOX4, SOX11 and SOX12) and SOX5 ( Supplementary Fig. 4 ). The transcription factors encoded by these SOX genes are crucial in regulating cell fate and differentiation [42] [43] [44] 46 , and a de novo deletion of SOX11 was described in a patient with autism and intellectual disability 47 . Moreover, Sox4 and Sox11 act as transcriptional activators 45 and their expression patterns overlap with that of Fezf2 in developing cortex ( Supplementary Fig. 5 ).
To determine whether SOX4 or SOX11 binds E4, we performed chromatin immunoprecipitation (ChIP)-PCR assays in Neuro-2a cells transiently expressing V5-tagged SOX4 or SOX11 (Methods). Anti-V5 antibodies precipitated E4 DNA, but not E1, E2 or E3 DNA, confirming binding of SOX4 and SOX11 to the E4 enhancer ( Fig. 3a) . Moreover, recruitment of RNA polymerase II to E4 occurred in the presence of SOX4 or SOX11, which is consistent with increased transcriptional activity. To test the functional consequence of SoxCgene expression on E4, we expressed a luciferase reporter under the control of E4 (pGL4-E4) in Neuro-2a cells (Fig. 3b ). Luciferase activity driven by the E4 enhancer was significantly increased by co-transfected Sox4 or Sox11, but not Sox12.
To dissect which sequences within E4 drive Fezf2 expression, we generated four truncated versions of the E4 sequence (E4F1to E4F4; Fig. 3c ). The luciferase activity of the E4F2 fragment was increased by SOX4 and SOX11, but not by SOX12 ( Fig. 3d ). Using 
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MATINSPECTOR, six potential SOX-binding sites within the E4F2 sequence were predicted. To define the precise base pairs with which SOXC proteins interact, we first tested whether the zebrafish E4F2 sequence, which has 74.2% sequence identity with mouse E4F2, is activated by SOXC proteins. Remarkably, the zebrafish E4F2 sequence was not activated by SOX11 ( Supplementary Fig. 6 ), indicating that the SOXC-interacting sequences of mouse E4F2 lie within the sequences that are divergent in zebrafish. Of the predicted SOXbinding sites in mouse E4F2, three putative SOX-binding sites (SB1 to SB3) are absent from zebrafish E4F2. To test the function and specificity of these sites, we generated mutant versions of E4F2 by substituting SB1, SB2 or SB3 with the zebrafish sequence ( Fig. 3e ). Only mutations of the mouse SB2 site significantly attenuated the ability of SOX4 and SOX11 to activate the luciferase reporter gene, indicating that this site is crucial to species differences in SOXC-mediated transactivation of E4. Next we assessed the ability of SOX4 and SOX11 to bind to the SB2 site in vitro, using an electrophoretic mobility shift assay. We synthesized V5-tagged SOX4 and a higher-affinity, but equally specific, truncated form of SOX11 (SOX11(1-276aa) ), because the binding affinity of native SOX11 is weak 43 . Biotinylated SB2 DNA was shifted in the presence of SOX4-V5 or SOX11(1-276aa)-V5 and supershifted to a higher molecular weight by an anti-V5 antibody (Fig. 3f ), but not when excess unlabelled or mutated SB2 DNA was used. Therefore, SOX4 and SOX11 directly bind to and activate the transcription activity of E4 via SB2.
To test whether SOX4 and SOX11 functionally compete with the repressor SOX5 in the transactivation of E4 (Fig. 3g) , we used the pGL4-E4 luciferase assay. Luciferase activity was significantly increased with increasing amounts of co-transfected Sox11 and, to a lesser extent, Sox4, whereas increased amounts of Sox5 significantly decreased luciferase activity (Fig. 3h, i) . Taken together, our sequence analysis and assays, both in vitro and in vivo, demonstrate that SOX4 and SOX11 functionally compete with SOX5 repression to activate Fezf2 transcription via direct binding to sites within E4.
Loss of Fezf2 expression and CS axons in cdKO mice
To test the phenotypic consequences of Sox4 and Sox11 inactivation, we generated cortex-specific deletions of Sox4 and Sox11 using the Emx1-Cre line (Methods) to circumvent the prenatal lethality associated with constitutive deletions of the two genes 44 Supplementary Fig. 7 ). However, in the absence of both Sox4 and Sox11, we observed a reduction in the size of the cerebral hemispheres and the olfactory bulb.
To assess the requirement of Sox4 and Sox11 in E4-mediated activity, we transfected primary cortical neurons cultured from heterozygous littermate control or Sox4;Sox11 cdKO embryos with control or E4-containing luciferase constructs (Fig. 4a) . In control neurons, the presence of E4 increased luciferase activity by a factor of 2.5 6 0.3 (P 5 1.9 3 10 24 ; one-tailed Student's t-test). This increase was abolished in neurons from Sox4;Sox11 cdKO (factor of 1.1 6 0.1; P 5 0.866), indicating that the two SOXC transcription factors are major activators of the enhancer in cortical neurons. SOX5. a, Chromatin immunoprecipitation (ChIP) from Neuro-2a cells expressing V5-tagged SOX4 and SOX11. Captured DNA was analysed by PCR using primers specific for E1-E4. SOX4 and SOX11 bound and recruited RNA polymerase II (Pol II) to E4 but not E1-E3. b, Analysis of SOXC transactivation using empty luciferase vectors (pGL4) or luciferase vectors containing E1-E3. The activity of E4, but not E1-E3, was significantly increased by Sox4 ($4-fold) and Sox11 ($13-fold), but not by Sox12 (#1.5-fold). c, d, Analysis of functional elements within E4 using luciferase vectors containing deletion fragments of E4 (E4F1 to E4F4) (c). E4F2, but not the other fragments, was significantly activated by co-transfection of Sox4 ($5-fold) and Sox11 ($9-fold), but not of 
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Next, using quantitative RT-PCR, we found a significant reduction in neocortical Fezf2 expression in cdKO littermates compared with control or single cKO littermates at postnatal day 0 (P0) (Fig. 4b ). In addition, immunostaining for L1CAM and PRKCG revealed a drastic loss of CS axons in Sox4;Sox11 cdKO mice but not in single cKO littermates at P0 and P6 (Fig. 4c, d and Supplementary Fig. 8 ), whereas the organization of other brainstem tracts was not affected. Because the absence of L1CAM and PRKCG labelling could reflect their downregulated expression, as opposed to loss of CS axons, in the cdKO mice, we confirmed the absence of the CS tract using the CREresponsive CAG-Cat-Gfp transgenic line to express GFP in all cortical projection neurons and their axons 39, 40 (Supplementary Fig. 9 ).
Two additional observations indicate that the loss of Fezf2 and CS axons in these mice was not due to an absence of L5 neurons. First, only a moderate increase in cell death was detected in the somatosensory-motor areas, in which CS axons originate ( Supplementary Fig. 10 ). Second, many BCL11B-immunopositive L5 neurons were present in the somatosensory-motor areas of cdKO mice, although lightly immunostained ( Supplementary Fig. 11 ), indicating that neurons that would normally give rise to the CS tract were present. Analysis of additional laminar markers further revealed an inversion of cortical layers similar to that of the reeler mutant mouse [10] [11] [12] (Supplementary Fig. 11 ), indicating that Sox4 and Sox11 are also required for proper laminar positioning of neurons. Previous studies have shown that the CS tract is present in reeler mice 12 , indicating that this laminar phenotype occurs independently of Fezf2 and probably in response to defects in the RELN signalling pathway 13, 14 . In support of this possibility, RELN was absent from cdKO mouse neocortex ( Supplementary Fig. 12 ). Thus, the combined deletion of Sox4 and Sox11 leads to defects in the laminar position of neurons and the molecular specification and connectivity of CS neurons.
Functional and evolutionary implications of E4 sequence variations
The differences in SOXC-mediated transcription between mouse E4F2 and zebrafish E4F2 suggest that species differences in the E4F2 sequence have functional implications. Analysis of SB1, SB2 and SB3 sites within the E4F2 sequence in 23 species revealed that SB2 is conserved in all analysed mammals and the two available nonmammalian amniotes (chicken and lizard) ( Supplementary Fig. 13 ). To investigate the functional consequences of species differences, we used luciferase assays in Neuro-2a cells to analyse the activity of E4F2 sequence from different vertebrates (Fig. 5a, b ) in response to SOX11, a more powerful transactivator than SOX4 ( Fig. 3) . Of the constructs containing an E4F2 sequence of a mammal (human, chimpanzee, macaque, or mouse) or non-mammalian amniote (chicken), which have conserved SB1-3 sequences, the luciferase reporter activity was strongly increased following co-transfection with Sox11. The reporter activity of a non-amniote tetrapod (Xenopus) E4F2 construct was moderately increased compared with the empty plasmid, but was not as high as that of the mammalian constructs (P 5 3.9 3 10 216 ; one-tailed Student's t-test; Fig. 5b ). By contrast, the reporter construct containing the zebrafish E4F2 sequence, the SB2 sequence of which is highly divergent from those of mammals, exhibited only basal level activity similar to the empty control luciferase plasmid. To confirm that this is dependent on sequence variations between species, we mutated zebrafish E4F2 by 'murinizing' its SB1, SB2 or SB3 sequence (ZeE4F2-m1, -m2 or -m3, respectively). Reporter activity of the murinized zebrafish SB2 (ZeE4F2-m2), but not SB1 or SB3, was robustly induced by SOX11 (Fig. 5c ). ZeE4F2-m2 murinization, however, was insufficient to restore the level of expression observed in the wild-type mouse sequence, suggesting the potential contribution of additional sequences. Thus, evolutionary differences in the E4F2 sequence, especially within SB2, are directly related to functional differences in the ability of SOX11 to activate this regulatory element.
Next, to investigate the functional consequences of species differences in the FEZF2 coding sequence, we tested the ability of zebrafish fezf2 to rescue the effects of mouse Fezf2 deficiency. We electroporated in utero the neocortical wall of the floxed Fezf2 (Fezf2 fl/fl ) mice 40 with Cre and CRE-responsive Gfp-expressing constructs with or without fezf2 at embryonic day 12.5 (E12.5) ( Fig. 5d ). Analysis of electroporated mice at P0 revealed that fezf2 was sufficient to rescue the formation of the CS tract in Fezf2-null mouse neurons (Fig. 5e ). Taken together, these results suggest that sequence variations in the E4 enhancer, but not the Fezf2 coding region, gave Fezf2 an essential role in CS tract evolution.
Discussion
Our data provide critical insight into the genes and regulatory components controlling CS system development, centring on the cis-regulation of Fezf2 by SOX4 and SOX11. We show that genetic inactivation of the E4 cis-regulatory module results in compartmentalized phenotypic effects largely limited to the loss of cortical Fezf2 expression and CS system. The spatio-temporal dynamics of cortical Fezf2 is further controlled by SOX5 and TBR1, two transcription factors expressed post-mitotically in projection neurons 39, 40, 46, 48, 49 . On its initial activation in early cortical progenitors, Fezf2 is highly expressed in deep-layer neurons during early corticogenesis but subsequently repressed in L6 neurons by SOX5 and TBR1 to create a postnatal L5-enriched pattern. The earlier expression of SOX4 and SOX11 is consistent with their role in Fezf2 activation before the L6 upregulation of SOX5, which is a functional competitor. Despite what is known about the function and regulation of Fezf2, a number of key questions have yet to be addressed. First, additional, as yet untested, trans-regulators and regulatory elements probably contribute to Fezf2 regulation in a context-dependent manner. These include the mediators of Fezf2 repression in L2, L3 and L4 projection neurons. Second, the distinct, and seemingly incongruous, effects of SOX5 in repressing Fezf2 but being independently required for CS tract formation 39 have not been resolved. Third, the direct transcriptional targets of FEZF2 in CS neurons remain largely unknown. 
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The laminar position and radial organization of projection neurons are key features of cortical development, which rely on RELN signalling [10] [11] [12] [13] [14] . We also show that SOX4 and SOX11 are crucial in regulating RELN expression and the inside-out pattern of cortical layer formation, independent of E4 or Fezf2 and probably involving interactions with distinct regulatory elements. Moreover, SOX4 and SOX11 have additional roles, as in mice lacking both genes, the cortex and olfactory bulb are smaller and cell death is increased. Thus, SOX4 and SOX11 have pleiotropic functions, which are probably mediated by distinct regulatory elements and downstream target genes that are involved in multiple developmental processes.
Our results indicate that, following their emergence in tetrapods, functional SOX-binding sites have retained high conservation through purifying selection in mammals and some amniotes, thus directly linking species variations in regulatory sequences to functional outcomes. E4 sequence substitutions in SB2 may constitute an evolutionary turning point for Fezf2 function during forebrain development, possibly facilitating the formation of descending telencephalic pathways including the CS system. Whereas minor projections from the ventral (subpallial) telencephalon to the spinal cord are present in amphibians 2 , direct dorsal telencephalo-spinal projections resembling the CS tract have been reported only in mammals and some birds 2, 50 . We propose that the concurrent emergence of the described regulatory mechanisms and direct telencephalo-spinal projections in early amniotes, together with subsequent changes in genetic programs driving the patterning and expansion of a six-layered dorsal pallium, made possible the evolution of the CS system in mammals.
METHODS SUMMARY
Selected CNEE sequences were deleted from a Fezf2-Gfp BAC by recombinationmediated genetic engineering, and GFP expression from modified BACs was analysed by transgenesis. To confirm the requirement of E4 enhancer for Fezf2 expression, a germline E4 deletion mutant was generated. Putative E4 transactivators SOX4 and SOX11, identified by E4 sequence and co-expression analyses, were tested using ChIP and luciferase reporter assays. To analyse the requirement of Sox4 and Sox11 for Fezf2 expression and cortical development, we generated cortex-specific single and double Sox4 and Sox11 null mice. Complete materials and methods are described in Supplementary Information. 
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